Voyager Therapeutics Inc (NASDAQ: VYGR) stock enjoyed a major increase of 13.5% on 3/1/24. The shares closed at $9.44. Moreover, trading volume in this advance was above average at 125% of normal. The stock has been weak relative to the market over the last nine months but has risen 22.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, VYGR is expected to be Value Creation neutral.
Voyager Therapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. Voyager Therapeutics has a slightly negative Power Rating of 34 and a very low Appreciation Score of 3, producing the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment